Sapna Srivastava - Net Worth and Insider Trading
Sapna Srivastava Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sapna Srivastava owns 9 companies in total, including Intellia Therapeutics Inc (NTLA) , Myos Rens Technology Inc (MYOS) , and MedAvail Holdings Inc (MDVLQ) among others .
Click here to see the complete history of Sapna Srivastava’s form 4 insider trades.
Insider Ownership Summary of Sapna Srivastava
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NTLA | Intellia Therapeutics Inc | 2016-05-05 | Chief Financial & Stategy Offr |
MYOS | Myos Rens Technology Inc | 2015-01-12 | director |
MDVLQ | MedAvail Holdings Inc | 2013-02-08 | director |
2021-10-28 | director | ||
2020-10-29 | director | ||
2021-05-06 | director | ||
2021-06-29 | director | ||
2021-07-28 | director | ||
2023-01-01 | director |
Sapna Srivastava Trading Performance
Sapna Srivastava Ownership Network
Ownership Network List of Sapna Srivastava
Ownership Network Relation of Sapna Srivastava
Sapna Srivastava Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Sapna Srivastava is the Chief Financial & Stategy Offr of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Sapna Srivastava made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Sapna Srivastava Mailing Address
Above is the net worth, insider trading, and ownership report for Sapna Srivastava. You might contact Sapna Srivastava via mailing address: C/o Myos Corporation, 45 Horsehill Road, Suite 106, Cedar Knolls Nj 07927.